S M Ali Selected Research

hydroxyethylcellulose

7/2001	Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: a placebo-controlled, double-blind study.
6/2000	Management of intravaginal warts in women with 5-fluorouracil (1%) in vaginal hydrophilic gel: a placebo-controlled double-blind study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S M Ali Research Topics

Disease

16	Neoplasms (Cancer) 01/2021 - 07/2001
9	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2001
2	Coma (Comas) 05/2017 - 10/2003
2	Lung Neoplasms (Lung Cancer) 01/2017 - 09/2014
2	Multiple Myeloma 10/2014 - 07/2001
2	Infections 05/2014 - 06/2000
2	Neoplasm Metastasis (Metastasis) 03/2004 - 06/2001
2	Carcinoma (Carcinomatosis) 12/2001 - 11/2001
2	Warts (Wart) 09/2000 - 06/2000
1	COVID-19 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Genetic Translocation (Chromosomal Translocation) 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Microsatellite Instability 01/2019
1	Poisoning 05/2017
1	Sleepiness 05/2017
1	Adenocarcinoma of Lung 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Mucoepidermoid Carcinoma 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 06/2015
1	Cross Infection (Nosocomial Infection) 03/2015
1	Eosinophilia 02/2015
1	Adrenocortical Carcinoma 11/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2014
1	Inflammation (Inflammations) 06/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2014
1	Tuberculosis (Tuberculoses) 01/2014
1	Ovarian Epithelial Carcinoma 09/2013
1	Thrombocytopenia (Thrombopenia) 09/2012
1	Sepsis (Septicemia) 09/2012
1	Bradycardia 07/2010
1	Peptic Ulcer (Peptic Ulcers) 05/2005
1	Ulcer 05/2005
1	Hemorrhage 05/2005

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2000
5	Estrogen ReceptorsIBA 01/2019 - 03/2002
4	Hormones (Hormone)IBA 02/2010 - 03/2002
4	CaspasesIBA 12/2001 - 03/2000
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2000
3	LipidsIBA 12/2001 - 09/2001
3	Peptide Hydrolases (Proteases)FDA Link 12/2001 - 09/2001
3	Photosensitizing Agents (Photosensitizers)IBA 12/2001 - 09/2001
2	Tamoxifen FDA LinkGeneric 01/2019 - 05/2003
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2014
2	Circulating Tumor DNAIBA 11/2017 - 01/2017
2	Formaldehyde (Formol)FDA Link 06/2015 - 09/2011
2	ParaffinIBA 06/2015 - 09/2011
2	thiamine triphosphorate (TTP)IBA 09/2011 - 03/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2005 - 02/2001
2	Aromatase InhibitorsIBA 05/2003 - 03/2002
2	Letrozole (Femara)FDA LinkGeneric 05/2003 - 03/2002
2	hypericinIBA 12/2001 - 11/2001
2	hypocrellin AIBA 12/2001 - 09/2001
2	Diphosphonates (Bisphosphonates)IBA 07/2001 - 06/2001
2	hydroxyethylcelluloseIBA 07/2001 - 06/2000
1	ZincIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	NucleophosminIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	ceritinibIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2019
1	NivolumabIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Oxazepam (Serax)FDA LinkGeneric 05/2017
1	NordazepamIBA 05/2017
1	Pharmaceutical PreparationsIBA 05/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	osimertinibIBA 01/2017
1	trametinibIBA 01/2017
1	NVP-BKM120IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	ribociclibIBA 01/2017
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 03/2015
1	Mupirocin (Bactroban)FDA LinkGeneric 03/2015
1	Imatinib Mesylate (Gleevec)FDA Link 02/2015
1	VemurafenibIBA 10/2014
1	C-Reactive ProteinIBA 06/2014
1	Ferritins (Ferritin)IBA 06/2014
1	Ether (Diethyl Ether)IBA 05/2014
1	AcidsIBA 01/2014
1	Dacarbazine (DIC)FDA LinkGeneric 09/2012
1	human ERBB2 proteinIBA 09/2011
1	Trastuzumab (Herceptin)FDA Link 09/2011
1	EndoglinIBA 02/2010
1	Edetic Acid (EDTA)FDA Link 02/2010
1	Proton Pump InhibitorsIBA 05/2005
1	collagen type I trimeric cross-linked peptideIBA 03/2004

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2001
1	Ligation 01/2017
1	Cesarean Section (Caesarean Section) 07/2010